相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis
Lenaig Mescam-Mancini et al.
BRAIN (2015)
Statin induced necrotizing autoimmune myopathy
Suma Babu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Myositis with endomysial cell invasion indicates inclusion body myositis even if other criteria are not fulfilled
J. van de Vlekkert et al.
NEUROMUSCULAR DISORDERS (2015)
Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients
Shigeaki Suzuki et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Abatacept as a successful therapy for myositis-a case-based review
Anne M. Kerola et al.
CLINICAL RHEUMATOLOGY (2015)
Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up
Mei Zong et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-alpha monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
Brandon W. Higgs et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
AUTOPHAGY MAY CONTRIBUTE TO GLUCOCORTICOID RESISTANCE IN MYOSITIS PATIENTS BY MAITAINING MUSCLE T CELLS HOMEOSTASIS
Mei Zong et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications
E. M. Moran et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Diagnosis, pathogenesis and treatment of myositis: recent advances
P. -O. Carstens et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Therapy of myositis: biological and physical
Ingrid E. Lundberg et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Long-term follow-up of 62 patients with myositis
Janneke van de Vlekkert et al.
JOURNAL OF NEUROLOGY (2014)
Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial
Nobuyuki Miyasaka et al.
Modern Rheumatology (2014)
Treatment of moderately to severely active systemic lupus erythematosus with adrenocorticotropic hormone: a single-site, open-label trial
J. J. Fiechtner et al.
LUPUS (2014)
The role of interleukin-17 in immune-mediated inflammatory myopathies and possible therapeutic implications
Ellen M. Moran et al.
NEUROMUSCULAR DISORDERS (2014)
An analysis of the sensitivity and specificity of MHC-I and MHC-II immunohistochemical staining in muscle biopsies for the diagnosis of inflammatory myopathies
Pedro M. Rodriguez Cruz et al.
NEUROMUSCULAR DISORDERS (2014)
Is Statin-Induced Myositis Part of the Polymyositis Disease Spectrum?
Jemima Albayda et al.
CURRENT RHEUMATOLOGY REPORTS (2014)
Predictors of Clinical Improvement in Rituximab-Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis
Rohit Aggarwal et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Cytosolic 5′-nucleotidase 1A autoimmunity in sporadic inclusion body myositis
H. Benjamin Larman et al.
ANNALS OF NEUROLOGY (2013)
Autoantibodies to cytosolic 5′-nucleotidase 1A in inclusion body myositis
Helma Pluk et al.
ANNALS OF NEUROLOGY (2013)
Low serum levels of vitamin D in idiopathic inflammatory myopathies
Payam Azali et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Ankylosing spondylitis patients with and without psoriasis do not differ in disease phenotype
Pedro Machado et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis
Maurizio Cutolo
ANNALS OF THE RHEUMATIC DISEASES (2013)
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis A Randomized, Placebo-Phase Trial
Chester V. Oddis et al.
ARTHRITIS AND RHEUMATISM (2013)
Complement-mediated muscle cell lysis: A possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM)
Arada Rojana-udomsart et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): A small pilot study
Michalis L. Kosmidis et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
STATIN-ASSOCIATED AUTOIMMUNE MYOPATHY AND ANTI-HMGCR AUTOANTIBODIES
Payam Mohassel et al.
MUSCLE & NERVE (2013)
The Vitamin D Receptor Agonist BXL-01-0029 as a Potential New Pharmacological Tool for the Treatment of Inflammatory Myopathies
Luigi Di Luigi et al.
PLOS ONE (2013)
Immune-Mediated Necrotizing Myopathy Is Characterized by a Specific Th1-M1 Polarized Immune Profile
Corinna Preusse et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Provision of an Explanation for the Inefficacy of Immunotherapy in Sporadic Inclusion Body Myositis Quantitative Assessment of Inflammation and β-Amyloid in the Muscle
Jana Zschuentzsch et al.
ARTHRITIS AND RHEUMATISM (2012)
Pathogenesis and therapies of immune-mediated myopathies
Marinos C. Dalakas
AUTOIMMUNITY REVIEWS (2012)
Tocilizumab - A novel therapy for non-organ-specific autoimmune diseases
Lisa Kaly et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2012)
Myositis autoantibodies
Livia Casciola-Rosen et al.
CURRENT OPINION IN RHEUMATOLOGY (2012)
Abatacept and Sodium Thiosulfate for Treatment of Recalcitrant Juvenile Dermatomyositis Complicated by Ulceration and Calcinosis
Bita Arabshahi et al.
JOURNAL OF PEDIATRICS (2012)
Review: Immune-mediated necrotizing myopathies - a heterogeneous group of diseases with specific myopathological features
W. Stenzel et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)
Rituximab as a first-line agent for the treatment of dermatomyositis
Muhammad Haroon et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series
Todd Levine
DRUG DESIGN DEVELOPMENT AND THERAPY (2012)
A Randomized, Pilot Trial of Etanercept in Dermatomyositis The Muscle Study Group
Anthony A. Amato et al.
ANNALS OF NEUROLOGY (2011)
Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis
Dandan Wang et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus
Lauren L. Ritterhouse et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: A novel application
Maria Giovanna Danieli et al.
AUTOIMMUNITY REVIEWS (2011)
Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: Report of 31 cases and review of the literature
Guillermo J. Pons-Estel et al.
AUTOIMMUNITY REVIEWS (2011)
Necrotizing autoimmune myopathy
Christina Liang et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Acquired immune and inflammatory myopathies: pathologic classification
Alan Pestronk
CURRENT OPINION IN RHEUMATOLOGY (2011)
The value of blocking IL-6 outside of rheumatoid arthritis: current perspective
Miho Murakami et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Abatacept for treatment of refractory polymyositis
Jorge L. Musuruana et al.
JOINT BONE SPINE (2011)
Use of intravenous immunoglobulin therapy during pregnancy in patients with pemphigus vulgaris
A. R. Ahmed et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry
Marion Couderc et al.
RHEUMATOLOGY (2011)
Therapeutic effect of tocilizumab on two patients with polymyositis
Masashi Narazaki et al.
RHEUMATOLOGY (2011)
Infectious Complications in Polymyositis and Dermatomyositis: A Series of 279 Patients
Isabelle Marie et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature
Yuki Ishikawa et al.
CLINICAL RHEUMATOLOGY (2010)
Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial
J. van de Vlekkert et al.
NEUROMUSCULAR DISORDERS (2010)
Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis
U. Holzer et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2010)
Rituximab Therapy for Myopathy Associated With Anti-Signal Recognition Particle Antibodies: A Case Series
Ritu Valiyil et al.
ARTHRITIS CARE & RESEARCH (2010)
Type 1 interferons and myositis
Steven A. Greenberg
ARTHRITIS RESEARCH & THERAPY (2010)
Dermatomyositis and Type 1 Interferons
Steven A. Greenberg
Current Rheumatology Reports (2010)
Antisignal recognition particle-positive polymyositis successfully treated with myeloablative autologous stem cell transplantation
J. C. Henes et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Therapeutic Effects of Interleukin-6 Blockade in a Murine Model of Polymyositis That Does Not Require Interleukin-17A
Naoko Okiyama et al.
ARTHRITIS AND RHEUMATISM (2009)
Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis
Marinos C. Dalakas et al.
BRAIN (2009)
Role of cytokines and chemokines in idiopathic inflammatory myopathies
Boel De Paepe et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Treatment of Adult Inflammatory Myositis With Rituximab An Emerging Therapy for Refractory Patients
Shefali Majmudar et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
T Cell Infiltrates in the Muscles of Patients with Dermatomyositis and Polymyositis Are Dominated by CD28null T Cells
Andreas E. R. Fasth et al.
JOURNAL OF IMMUNOLOGY (2009)
Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion
Bryan R. Whelan et al.
RHEUMATOLOGY (2009)
Efficacy of rituximab in refractory and relapsing myositis with anti-JO1 antibodies: a report of two cases
Faten Frikha et al.
RHEUMATOLOGY (2009)
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
M. Dastmalchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Interrelation of inflammation and APP in sIBM:: IL-1β induces accumulation of β-amyloid in skeletal muscle
Jens Schmidt et al.
BRAIN (2008)
Open-label trial of anti-TNF-alpha in dermato- and polymyositis treated concomitantly with methotrexate
G. J. D. Hengstman et al.
EUROPEAN NEUROLOGY (2008)
Improving Undergraduate Musculoskeletal Education: A Continuing Challenge
Andrew E. Thompson
JOURNAL OF RHEUMATOLOGY (2008)
Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications
Steven A. Greenberg
NEUROLOGY (2007)
T cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis
M. Salajegheh et al.
NEUROLOGY (2007)
Rituximab for the treatment of juvenile dermatomyrositis - A report of four pediatric patients
Megan A. Cooper et al.
ARTHRITIS AND RHEUMATISM (2007)
Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches
Merrilee Needham et al.
LANCET NEUROLOGY (2007)
Treatment of early and refractory dermatomyositis with infliximab: a report of two cases
Sylvia Dold et al.
CLINICAL RHEUMATOLOGY (2007)
A pilot trial of rituximab in the treatment of patients with dermatomyositis
Lorinda Chung et al.
ARCHIVES OF DERMATOLOGY (2007)
Progressive myopathy with up-regulation of MHC-I associated with statin therapy
Merrilee Needham et al.
NEUROMUSCULAR DISORDERS (2007)
Vitamin D and autoimmunity: New aetiological and therapeutic considerations
Yoav Arnson et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Expression of granulysin in polymyositis and inclusion-body myositis
K. Ikezoe et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients
P. Efthimiou et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Brachio-cervical inflammatory myopathies - Clinical, immune, and myopathologic features
A Pestronk et al.
ARTHRITIS AND RHEUMATISM (2006)
Mechanisms of Disease: signaling pathways and immunobiology of inflammatory myopathies
MC Dalakas
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Therapeutic targets in patients with inflammatory myopathies: Present approaches and a look to the future
MC Dalakas
NEUROMUSCULAR DISORDERS (2006)
Pilot trial of etanercept in the treatment of inclusion-body myositis
RJ Barohn et al.
NEUROLOGY (2006)
Rituximab in the treatment of refractory dermatomyositis
N Chiappetta et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2005)
Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies -: Analysis of 100 French Canadian patients
Y Troyanov et al.
MEDICINE (2005)
Advanced refractory polymyositis responding to infliximab
A Anandacoomarasamy et al.
RHEUMATOLOGY (2005)
Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy
M Mosca et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Treatment of myositis with etanercept (Enbrel®), a recombinant human soluble fusion protein of TNF-α type II receptor and IgG1
H Sprott et al.
RHEUMATOLOGY (2004)
Refractory polymyositis responding to infliximab: Extended follow-up
I Labioche et al.
RHEUMATOLOGY (2004)
Targeting melanocortin receptors as a novel strategy to control inflammation
A Catania et al.
PHARMACOLOGICAL REVIEWS (2004)
Refractory polymyositis responding to infliximab
I Uthman et al.
RHEUMATOLOGY (2004)
Long-term persistence of clonally expanded T cells in patients with polymyositis
O Benveniste et al.
ANNALS OF NEUROLOGY (2004)
Anti-T-lymphocyte globulin treatment in inclusion body myositis - A randomized pilot study
C Lindberg et al.
NEUROLOGY (2003)
Polymyositis associated with infliximab treatment for rheumatoid arthritis
J Musial et al.
RHEUMATOLOGY (2003)
Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: Preliminary observations
GJD Hengstman et al.
EUROPEAN NEUROLOGY (2003)
Inflammatory myopathies: how to treat the difficult cases
FL Mastaglia et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2003)
The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy
D McGonagle et al.
ARTHRITIS AND RHEUMATISM (2002)
A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM
MC Dalakas et al.
NEUROLOGY (2001)
Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time - Studies in repeated muscle biopsies
K Amemiya et al.
BRAIN (2000)
High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study
MC Walter et al.
JOURNAL OF NEUROLOGY (2000)
Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis
T Shimizu et al.
CLINICAL RHEUMATOLOGY (2000)
分享论文
